BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29222866)

  • 1. Outcome of antibody-mediated rejection compared to acute cellular rejection after pediatric heart transplantation.
    Vaughn GR; Jorgensen NW; Law YM; Albers EL; Hong BJ; Friedland-Little JM; Kemna MS
    Pediatr Transplant; 2018 Feb; 22(1):. PubMed ID: 29222866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.
    Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG
    J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of rejection risk following subtherapeutic calcineurin inhibitor levels after pediatric heart transplantation.
    Kerr SM; Jorgensen NW; Hong BJ; Friedland-Little JM; Albers EL; Newland DM; Law YM; Kemna MS
    Pediatr Transplant; 2020 Feb; 24(1):e13616. PubMed ID: 31820529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal Myocardial Contractility After Pediatric Heart Transplantation by Cardiac MRI.
    Grotenhuis HB; Nyns ECA; Kantor PF; Dipchand AI; Greenway SC; Yoo SJ; Tomlinson G; Chaturvedi RR; Grosse-Wortmann L
    Pediatr Cardiol; 2017 Aug; 38(6):1198-1205. PubMed ID: 28555404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population.
    Pollock-BarZiv SM; den Hollander N; Ngan BY; Kantor P; McCrindle B; West LJ; Dipchand AI
    Circulation; 2007 Sep; 116(11 Suppl):I172-8. PubMed ID: 17846300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Novo Anti-HLA Antibodies After Heart Transplantation Are Associated With Adverse Events in the Long-term Follow-up of Cardiac Transplant Recipients.
    Solé-González E; Mirabet S; Brossa V; López-López L; Rivas-Lasarte M; Capellades-Olivella H; Ginel-Iglesias AJ; Martorell-Pons J; Roig E
    Transplant Proc; 2016 Nov; 48(9):3030-3032. PubMed ID: 27932139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation.
    Kfoury AG; Snow GL; Budge D; Alharethi RA; Stehlik J; Everitt MD; Miller DV; Drakos SG; Reid BB; Revelo MP; Gilbert EM; Selzman CH; Bader FM; Connelly JJ; Hammond ME
    J Heart Lung Transplant; 2012 Jan; 31(1):46-51. PubMed ID: 22153551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation.
    Almond CS; Hoen H; Rossano JW; Castleberry C; Auerbach SR; Yang L; Lal AK; Everitt MD; Fenton M; Hollander SA; Pahl E; Pruitt E; Rosenthal DN; McElhinney DB; Daly KP; Desai M;
    J Heart Lung Transplant; 2018 Apr; 37(4):441-450. PubMed ID: 28465118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil count, allergies, and rejection in pediatric heart transplant recipients.
    Arbon KS; Albers E; Kemna M; Law S; Law Y
    J Heart Lung Transplant; 2015 Aug; 34(8):1103-11. PubMed ID: 25987311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?
    Mohamedali B; Pyle J; Bhat G
    Am J Clin Pathol; 2016 Feb; 145(2):238-43. PubMed ID: 26767383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
    Pascual J; Pirsch JD; Odorico JS; Torrealba JR; Djamali A; Becker YT; Voss B; Leverson GE; Knechtle SJ; Sollinger HW; Samaniego-Picota MD
    Transplantation; 2009 Jan; 87(1):125-32. PubMed ID: 19136902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of Cardiac Deformation in Acute Rejection in Pediatric Heart Transplant Recipients.
    Chanana N; Van Dorn CS; Everitt MD; Weng HY; Miller DV; Menon SC
    Pediatr Cardiol; 2017 Apr; 38(4):691-699. PubMed ID: 28161809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations.
    Kfoury AG; Miller DV; Snow GL; Afshar K; Stehlik J; Drakos SG; Budge D; Fang JC; Revelo MP; Alharethi RA; Gilbert EM; Caine WT; McKellar S; Molina KM; Hammond MEH
    J Heart Lung Transplant; 2016 Mar; 35(3):335-341. PubMed ID: 26586489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs in cellular and antibody-mediated heart transplant rejection.
    Shah P; Agbor-Enoh S; Bagchi P; deFilippi CR; Mercado A; Diao G; Morales DJ; Shah KB; Najjar SS; Feller E; Hsu S; Rodrigo ME; Lewsey SC; Jang MK; Marboe C; Berry GJ; Khush KK; Valantine HA;
    J Heart Lung Transplant; 2022 Oct; 41(10):1401-1413. PubMed ID: 35872109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated rejection in pediatric liver transplant recipients.
    Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Rękawek A; Jankowska I; Kostecka E; Kurowski PN
    Ann Transplant; 2014 Mar; 19():119-23. PubMed ID: 24594760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection.
    Jackups R; Canter C; Sweet SC; Mohanakumar T; Morris GP
    J Clin Apher; 2013 Aug; 28(4):301-8. PubMed ID: 23426730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the Number of HLA-DR Mismatches With Early Post-transplant Acute Cellular Rejection Among Heart Transplantation Recipients: A Cohort Study in Japanese Population.
    Nitta D; Kinugawa K; Imamura T; Iino J; Endo M; Amiya E; Hatano M; Kinoshita O; Nawata K; Ono M; Komuro I
    Transplant Proc; 2017; 49(1):125-129. PubMed ID: 28104119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.